It supports red blood cell formation, and it also improves oxygen delivery
All content, including text, graphics, images, and information available through this email is for general information purposes only
Receptor Grade IGF-1 LR3 and Shorter Action An experimental mouse model was created for a study (8) where the IGF-1 LR3 peptide was compared to the endogenous IGF-1
You may also like Product Description IGF-1 LR3 Peptide | Buy IGF-1 LR3 UK | Long Arginine 3 IGF-1 Analogue | Research Use Only IGF-1 LR3 (Long Arginine 3 IGF-1) is a synthetic 83-amino acid analogue of human Insulin-like Growth Factor-1, engineered with an N-terminal 13-amino acid extension and a Glu3Arg3 substitution that dramatically reduces binding to IGF-binding proteins (IGFBPs), extends half-life to 2030 hours, and increases in vivo potency approximately three-fold versus native IGF-1 making it one of the most widely used and thoroughly characterised IGF-1 analogues in pre-clinical and cell biology research today
The human doses were converted to mouse-equivalent doses using a standard adult human body weight of 60 kg, resulting in the following dosages: 0.00166 g/kg/day for glutathione, 0.00666 g/kg/day for Ganoderma lucidum extract, and 0.00666 g/kg/day for vitamin C
p62, also known as sequestosome 1, is a multifunctional junction protein involved in a number of cellular processes including autophagy, signaling and protein degradation (78)
